Biogen Inc
XETRA:IDP

Watchlist Manager
Biogen Inc Logo
Biogen Inc
XETRA:IDP
Watchlist
Price: 139.5 EUR 0.5% Market Closed
Market Cap: 20.3B EUR

Wall Street
Price Targets

IDP Price Targets Summary
Biogen Inc

Wall Street analysts forecast IDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDP is 163.18 EUR with a low forecast of 121.96 EUR and a high forecast of 230.53 EUR.

Lowest
Price Target
121.96 EUR
13% Downside
Average
Price Target
163.18 EUR
17% Upside
Highest
Price Target
230.53 EUR
65% Upside
Biogen Inc Competitors:
Price Targets
HCAT
Health Catalyst Inc
76% Upside

Revenue
Forecast

5% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

Operating Income
Forecast

2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

Net Income
Forecast

2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
19%
Average Beat
2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
19%
Average Beat

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDP's stock price target?
Price Target
163.18 EUR

According to Wall Street analysts, the average 1-year price target for IDP is 163.18 EUR with a low forecast of 121.96 EUR and a high forecast of 230.53 EUR.

What is Biogen Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Back to Top